CanadaBis Capital Reports Q3 2025 Financial Results

*CALGARY, AB –* CanadaBis Capital, a cannabis and concentrates producer,
reported its first-auarter fiscal 2025 financial results for the
three-month period ending April 30, 2025.

Despite a challenging market environment, the Company is pleased to report
an adjusted EBITDA of positive $440,665 for Q3 2025, demonstrating
resilience and operational efficiency.

Travis McIntyre, CEO of CanadaBis Capital, stated, “Our ability to achieve
positive EBITDA in this challenging market is a testament to our team’s
dedication and our strategic focus on cost management and product
innovation. The successful launch of our diamond and Keef-coated pre-rolls
not only showcases our commitment to quality but also our responsiveness to
market trends. The improvement in gross profit as a percentage of revenue
reflects our operational efficiency. As we prepare to introduce our
revolutionary vape hardware later this year, we look forward to
re-establishing Stigma Grow’s presence in the vape market with our
innovative and high-quality offerings. As we continue to reduce our debt
and optimize our operations, we are well-positioned for future growth.”
Financial Highlights

Gross Revenue: CanadaBis achieved gross revenue of $5.5 million for Q3
2025, reflecting a strategic decision to delist marginally profitable SKUs
from provincial boards amid seasonally weak cannabis sales.
Gross Revenue and Net Income Insights

Efficiency Improvement: Gross profit as a percentage of gross revenue
increased by 6%, indicating a significant enhancement in operating
efficiency during this period.

Cost Savings: The Company successfully reduced Selling, General and
Administrative expenses (SG&A) to $1.4 million, a significant decrease of
30% from $1.8 million in the same period last year. This cost control
initiative has been crucial in maintaining positive EBITDA levels.

Adjusted EBITDA: Despite the decrease in revenue, adjusted EBITDA remained
robust at $440,665, staying on track with comparative quarters with higher
gross revenue showing that cost cutting measures and optimization
strategies are working giving way for larger up side in future periods.

Debt Reduction: CanadaBis has made significant strides in improving its
financial health by reducing its short-term debt by $2.5 million during the
quarter.

Product Launch: The Company successfully launched its new line of 50’s
diamond and Keef-coated pre-rolls, which have been sold out multiple times
throughout the later part of the quarter, underscoring strong market demand.

Liquidity Position: In early April 2025, CanadaBis closed a brokered
private placement, raising gross proceeds of $4,035,000 from the issuance
of 4,035 unsecured 11% convertible debentures. This financing has
strengthened the Company’s short-term liquidity, positioning it for
strategic growth opportunities.
Operational Focus

CanadaBis continues to focus on optimizing its operations through input and
manufacturing cost control, SKU rationalization, and effective inventory
management. The total SKU count in the Company’s three largest provinces
has been reduced to 83 as of April 30, 2025, from 111 as of January 31,
2025.

The Company is now evaluating opportunities to expand its offerings in
flower sales and licensing its brands internationally, in addition to bulk
extract sales through business-to-business channels domestically.
About CanadaBis Capital Inc.

CanadaBis Capital Inc. (TSXV: CANB) is a vertically integrated Canadian
cannabis company focused on achieving large-scale growth in the global
cannabis market producing high-quality cannabis products and building a
portfolio of trusted brands. CanadaBis is committed to delivering value to
shareholders and exploring innovative pathways for growth.